Clinical trials listed for ITP are a starting point for discussion with a healthcare professional. Be sure you understand all the implications of the proposed treatment by reading the informed consent very carefully and speaking with your doctor before enrolling in a clinical trial.
What are Clinical Trials?
Clinical Trials are controlled patient studies that must be performed before a new drug or treatment is approved by the Food and Drug Administration (FDA) in the United States and similar organizations in other countries. Clinical trials are also completed after a drug or treatment is approved to document the effectiveness of the treatment, or to gain approval to use the drug or therapy for a different disease or age group.
There are three main phases to clinical trials, completed in sequence. A Phase I study tests the safety and side effects of the drug. A Phase II study is initiated to determine the efficacy of the drug, to see if it works as anticipated. And, a Phase III study tests the efficacy of drug or treatment and documents the side effects in a large population of volunteers.
Finding a Clinical Trial
The best way to find the latest information on clinical trials is by visiting ClinicalTrials.gov, a database of privately and publicly funded clinical studies conducted around the world. Pharmaceutical companies and researchers update this site frequently to ensure it contains the most comprehensive and up-to-date clinical trial listings. The database features an easy-to-use search facility and detailed guidance for patients and industry.
Featured Clinical Trials
ADVANCE NEXT global phase 3 confirmatory study is open for certain people living with ITP to join. The study, or clinical trial, is looking at a drug called efgartigimod IV for treating primary immune thrombocytopenia (ITP).
The study lasts about 2.5 years and includes a screening period, a treatment period, and a follow-up period. During the first 24 weeks, participants will get either the new drug or a placebo. After that, everyone can get the new drug. The study is looking for 69 adults with primary ITP. You may join if you were diagnosed at least a year ago and have tried other treatments that may no longer be working well for you. There is no cost to join, and you may get travel expenses covered. For more details, please contact your hematologist, visit clinicaltrials.gov and search for NCT06544499 or email argenx Patient Advocacy Lead at sgerson@argenx.com.
List of Clinical Trials:
(Select from the list below)- Clinical Trials Actively Recruiting in the USA
- Clinical Trials Actively Recruiting in Canada
- Clinical Trials Actively Recruiting Internationally
- Clinical Trials Active But Not Recruiting
- Completed Clinical Trials
- Clinical Trials for Other Platelet Disorders
Please contact PDSA if you find missing or incorrect information regarding any of the clinical trials listed.